Samples supplied by the client (such as gDNA, RNA, cell pellets, or tissue sections) together with relevant clinical/phenotypic information (where applicable).
Deciphering ALMS1: From Gene to Function to Therapeutic Insight
Accelerate your research into ciliopathies and rare genetic disorders! Are you currently facing challenges in validating ALMS1 gene variants, characterizing protein function, or establishing robust cellular models for Alström syndrome? Our comprehensive ALMS1 Analysis Services leverage cutting-edge genomic, proteomic, and cell biology platforms to help you elucidate disease mechanisms, identify novel therapeutic targets, and advance your preclinical development with confidence and precision.
Overview of ALMS1 Analysis Services
Mutations in the ALMS1 gene are causative for Alström syndrome, a rare ciliopathy with multisystemic manifestations. Recent literature extends ALMS1's relevance to broader ciliary biology, cellular energy sensing, and adipogenesis. Effective therapeutic development requires a holistic analysis strategy that moves beyond variant identification to functional validation in cellular and subcellular contexts. Our integrated service portfolio provides this essential bridge from genetic discovery to mechanistic understanding.
| Technical Method | Core Principle | Primary Application in ALMS1 Analysis |
|---|---|---|
| Next-Generation Sequencing (NGS) | High-throughput parallel sequencing | Comprehensive detection of SNVs, indels, and splicing variants across the entire ALMS1 locus. |
| Sanger Sequencing | Capillary electrophoresis-based sequencing | Gold-standard validation of NGS findings or targeted analysis of specific exons. |
| qPCR & Digital PCR | Quantitative nucleic acid amplification | Accurate evaluation of ALMS1 expression levels and analysis of copy number variations. |
| Immunofluorescence (IF) & Confocal Microscopy | Antibody-mediated protein detection employing high-resolution imaging. | Evaluation of ALMS1 protein localization, ciliary architecture, and co-localization analyses. |
| Western Blotting | Protein separation and immunodetection | Analysis of ALMS1 protein expression, size, and potential truncations. |
| Cell-Based Functional Assays | Phenotypic readouts in engineered cell lines | Evaluation of ciliogenesis, cell cycle progression, and metabolic responses post-ALMS1 modulation. |
How Creative Biolabs' Service Can Assist Your Project?
Our ALMS1 Analysis Service delivers a complete functional profile for your gene of interest. We provide definitive data on mutation impact, protein expression and localization, and resulting cellular phenotypes, enabling you to prioritize variants for further study and build a compelling case for therapeutic mechanisms.
Explore How We Can Assist You – Initiate a Consultation Request.
Service Workflow
Our process is designed for scientific rigor and transparency, ensuring reliable and actionable data at every stage.
01Project Initiation & Sample QC
Client-provided samples (e.g., gDNA, RNA, cell pellets, or tissue sections) along with associated clinical/phenotypic data (if applicable). We also accept cell lines for model generation.
02Genomic & Transcriptomic Analysis
NGS panel or whole-exome sequencing for variant discovery, followed by Sanger validation. Optional mRNA analysis to assess splicing anomalies.
03Protein-Level Characterization
Development of optimized protocols for ALMS1 detection via Western Blot and Immunofluorescence/Confocal Microscopy, including ciliary staining.
04Cellular Phenotyping & Functional Assays
Execution of tailored cell-based assays. This may include ciliogenesis induction and quantification, analysis of cell cycle profiles, or assessment of metabolic markers in ALMS1-deficient or patient-derived cells.
05Data Integration & Reporting
Synthesis of all genetic, protein, and cellular data into a coherent narrative. Statistical analysis and correlation with provided phenotypic information.
Applications
Project Initiation & Sample Quality Control
Disease Mechanism Elucidation
Investigating the role of specific ALMS1 mutations in disrupting ciliary assembly, protein trafficking, or signaling pathways (e.g., mTOR, AMPK) to uncover novel pathogenic mechanisms.
Therapeutic Target Validation
Utilizing ALMS1-knockdown or patient-derived cell models to screen and validate the efficacy of small molecule drugs, gene therapy vectors, or other modalities designed to rescue ciliary or metabolic phenotypes.
Biomarker Discovery & Assay Development
Detecting and measuring ALMS1-associated molecular signatures (transcriptional, proteomic) in cellular or fluid samples to facilitate the creation of companion diagnostics.
Preclinical Model Characterization
Thoroughly validating genetically engineered cellular or animal models by confirming ALMS1 mutation status, protein expression patterns, and expected cellular dysfunctions prior to interventional studies.
Published Data
Fig.1 Identification and localization of ALMS1 protein in HL cells.1
A seminal study published systematically characterized fibroblasts from Alström syndrome patients. The research combined genetic confirmation of ALMS1 mutations with rigorous cellular phenotyping. Key findings, achieved through immunofluorescence and functional assays, demonstrated that patient cells exhibited significantly impaired ciliogenesis and altered cell cycle progression. This work underscores the critical need for integrated ALMS1 analysis that links genotype to observable cellular dysfunction, a methodology central to our service offering for validating disease models and therapeutic responses.
Why Choose Us?
- Integrated Multi-Omics Approach: We uniquely combine genomic sequencing with direct protein visualization and live-cell functional readouts. This orthogonal validation ensures observations at the DNA/RNA level are conclusively linked to biological impact, reducing the risk of misinterpretation.
- Specialization in Challenging Targets: ALMS1 is a large, repetitive, and low-abundance protein. Our optimized protocols for detection and localization, especially within the primary cilium, are honed through extensive experience, providing clear data where standard methods often fail.
- Actionable, Interpretative Reporting: We deliver more than raw data files. Our reports provide expert biological interpretation, connecting your results to established disease mechanisms and suggesting clear next steps for research or development.
- Proven Expertise in Ciliary Biology: Our team possesses deep domain expertise in ciliopathies. This scientific leadership translates into insightful experimental design, relevant assay selection, and a nuanced understanding of your data's significance in the field.
Discover the Creative Biolabs Advantage - Request a Quote Today.
Frequently Asked Questions
-
What is the advantage of your service over standard commercial genetic testing for ALMS1?
While genetic tests identify variants, our service provides the essential functional validation. We determine if and how a variant affects protein localization and cellular function, which is crucial for interpreting pathogenicity and understanding disease mechanism, especially for novel.
-
Can you analyze ALMS1 in tissues other than fibroblasts?
Absolutely. We have experience working with various cell types, including induced pluripotent stem cells (iPSCs), differentiated cell lineages (e.g., adipocytes, hepatocytes), and tissue sections. We can tailor sample preparation and staining protocols to your specific research model.
-
Do you offer services to create ALMS1-modified cell lines?
Yes. We provide gene editing services to generate knockout, knock-in, or site-specific mutant cell lines, which can then be fully characterized using our ALMS1 analysis pipeline to establish isogenic models for your studies.
-
How much biological material is required to start a project?
Requirements vary by assay. For genomic sequencing, nanograms of high-quality DNA suffice. For protein and cellular assays, we typically need cell pellets from at least one 6-well plate confluency. We provide detailed sample requirement guidelines upon project consultation.
-
Can you help design a custom analysis plan for a specific therapeutic hypothesis?
Definitely. Our consultations are designed to understand your specific goals. We will propose a tailored combination of our available techniques to most effectively test your hypothesis, whether it involves drug screening, biomarker analysis, or mechanistic investigation.
If you are interested in our services,
| Cat | Service |
| BAS87-1 | ALMS1 Knockdown Assay |
| BAS87-2 | ALMS1 Protein Analysis |
| BAS87-3 | ALMS1 mRNA Analysis |
| BAS87-4 | MS & Bioinformatic Analysis |
| BAS87-5 | Cell Cycle Assay |
| BAS87-6 | Apoptosis Assay |
| BAS87-7 | Mitochondrial Activity Assay |
| BAS87-8 | ALMS1 PTM Analysis |
| BAS87-9 | ALMS1 Mutation Analysis |
Contact Us
Creative Biolabs stands as a premier provider of specialized molecular and cellular analysis services. Our dedicated ALMS1 Analysis platform is designed to empower your research into Alström syndrome and ciliary biology, transforming complex genetic data into clear, actionable insights for target validation and therapeutic development, please reach out to our senior scientific team.
Reference
- Braune, Katarina, Ines Volkmer, and Martin S. Staege. "Characterization of Alstrom syndrome 1 (ALMS1) transcript variants in Hodgkin lymphoma cells." PLoS One 12.1 (2017): e0170694. Distributed under Open Access license CC BY 4.0, without modification. Doi: https://doi.org/10.1371/journal.pone.0170694.
For Research Use Only.